ファンクショナルサービスプロバイダー（FSP）の世界市場の予測（～2027年）

世界のファンクショナルサービスプロバイダー（FSP）の市場規模は、調査期間にCAGRで7.49%の健全な成長が予測されています。

市場は、研究開発ベンチャーの拡大、前臨床試験の増加、医薬品改良におけるFSPアウトソーシングの台頭などのさまざまな要素によって牽引されています。

特にバイオ製薬企業やバイオテクノロジー企業における研究開発活動の高まりが、世界市場におけるファンクショナルサービスプロバイダー（FSP）の需要を高めています。調査によると、大手バイオ製薬企業によるFSPの利用は、年間13％以上のペースで拡大しています。

地域の考察

北米市場は、2022年に約41%のシェアを占め、最大の市場を形成しました。これは、確立された医療基盤や無数の前臨床試験、IQVIA（米国）、Parexel（米国）、Labcorp Medication Improvement（米国）などのこの地域の重要な中心的企業のプレゼンスによるものです。

欧州市場は、技術革新の進行、医療消費の拡大、慢性疾患の拡大により、第2位の市場シェアを占めています。EMAによると、EU加盟国全体で常に約4,000件の臨床試験が行われています。ドイツが2022年に最大の市場シェアを占め、フランスが欧州でもっとも急速に発展する市場となる見込みです。

アジア太平洋市場が2023年～2027年にもっとも急速に発展する見込みです。

当レポートでは、世界のファンクショナルサービスプロバイダー（FSP）市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

• 概要
• 促進要因
  • 研究開発投資の増加
  • 臨床試験の増加
  • 経営コストの削減とサービス品質の向上
  • 医薬品開発におけるFSPアウトソーシングの増加
• 抑制要因
  • 熟練労働者の不足
• 機会
  • バイオ製薬とバイオテクノロジーのデジタルトランスフォーメーション

第5章 市場要因の分析

• バリューチェーン分析
  • 顧客の獲得（購入前の問い合わせ）
  • サービスのカスタマイズ
  • 顧客の購入サポート
  • 顧客フルフィルメント・購入後サポート
• ポーターのファイブフォース分析モデル
• ファンクショナルサービスプロバイダー（FSP）市場に対するCOVID-19の影響
  • 概要
  • ファンクショナルサービスプロバイダー（FSP）の需要に対する影響

第6章 世界のファンクショナルサービスプロバイダー（FSP）市場：タイプ別

• 概要
• 臨床モニタリング
• メディカルライティング
• データ管理
• 医薬品安全性監視
• 生物統計学/プログラミング
• 規制関連業務
• その他

第7章 世界のファンクショナルサービスプロバイダー（FSP）市場：段階別

• 概要
• 臨床開発
• 承認後

第8章 世界のファンクショナルサービスプロバイダー（FSP）市場：用途別

• 概要
• バイオ製薬企業
• バイオテクノロジー企業
• 医療機器企業
• 研究センター、学術機関

第9章 世界のファンクショナルサービスプロバイダー（FSP）市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• その他の地域
  • ラテンアメリカ
  • 中東
  • アフリカ

第10章 競合情勢

• 概要
• 競合ベンチマーキング
• 世界のファンクショナルサービスプロバイダー（FSP）市場における主な成長戦略
• 世界のファンクショナルサービスプロバイダー（FSP）市場の開発数における主要企業
• 主な発展の分析
• 主な発展と成長戦略
  • 製品の発売
  • パートナーシップ
  • 買収
• 主要企業の財務マトリクス
  • 売上（2022年）
  • 研究開発支出（2022年）

第11章 企業プロファイル

• IQVIA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• ICON PLC
• KPS LIFE, LLC
• WUXI APPTEC CO., LTD.
• PPD INC.
• PAREXEL INTERNATIONAL CORPORATION
• QUANTICATE INTERNATIONAL LIMITED
• BIOPOINT INC.
• RHO, INC.

第12章 付録

LIST OF TABLES

• TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
• TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
• TABLE 3 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 4 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR CLINICAL MONITORING, BY REGION, 2018-2027 (USD MILLION)
• TABLE 5 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR MEDICAL WRITING, BY REGION, 2018-2027 (USD MILLION)
• TABLE 6 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR DATA MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
• TABLE 7 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR PHARMACOVIGILANCE, BY REGION, 2018-2027 (USD MILLION)
• TABLE 8 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOSTATISTICS/PROGRAMMING, BY REGION, 2018-2027 (USD MILLION)
• TABLE 9 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR REGULATORY AFFAIRS, BY REGION, 2018-2027 (USD MILLION)
• TABLE 10 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
• TABLE 11 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 12 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR CLINICAL DEVELOPMENT, BY REGION, 2018-2027 (USD MILLION)
• TABLE 13 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR POST APPROVAL, BY REGION, 2018-2027 (USD MILLION)
• TABLE 14 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 15 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOPHARMA COMPANIES, BY REGION, 2018-2027 (USD MILLION)
• TABLE 16 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOTECH COMPANIES, BY REGION, 2018-2027 (USD MILLION)
• TABLE 17 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR MEDICAL DEVICES COMPANIES, BY REGION, 2018-2027 (USD MILLION)
• TABLE 18 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR RESEARCH CENTER AND ACADEMIC INSTITUTES, BY REGION, 2018-2027 (USD MILLION)
• TABLE 19 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 20 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 21 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 22 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 23 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 24 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 25 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 26 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 27 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 28 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 29 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 30 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 31 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 32 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 33 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 34 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 35 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 36 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 37 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 38 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 39 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 40 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 41 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 42 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 43 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 44 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 45 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 46 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 47 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 48 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 49 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 50 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 51 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 52 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 53 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 54 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 55 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 56 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 57 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 58 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 59 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 60 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 61 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 62 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 63 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 64 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 65 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 66 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 67 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 68 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 69 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 70 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 71 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 72 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 73 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 74 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 75 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 76 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 77 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 78 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 79 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 80 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 81 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 82 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 83 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 84 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
• TABLE 85 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
• TABLE 86 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
• TABLE 87 MAJOR PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• TABLE 88 MOST ACTIVE PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• TABLE 89 PRODUCT LAUNCHES
• TABLE 90 PARTNERSHIPS
• TABLE 91 ACQUISITIONS
• TABLE 92 IQVIA INC.: SOLUTIONS/SERVICES OFFERED
• TABLE 93 IQVIA INC.: KEY DEVELOPMENTS
• TABLE 94 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES OFFERED
• TABLE 95 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS
• TABLE 96 ICON PLC: PRODUCTS/SERVICES OFFERED
• TABLE 97 KPS LIFE, LLC: PRODUCTS/SERVICES OFFERED
• TABLE 98 WUXI APPTEC CO., LTD.: SOLUTIONS/SERVICES OFFERED
• TABLE 99 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS
• TABLE 100 PPD INC.: SOLUTIONS/SERVICES OFFERED
• TABLE 101 PAREXEL INTERNATIONAL CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 102 PAREXEL INTERNATIONAL CORPORATION: KEY DEVELOPMENTS
• TABLE 103 QUANTICATE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED
• TABLE 104 QUANTICATE INTERNATIONAL LIMITED: KEY DEVELOPMENTS
• TABLE 105 BIOPOINT INC.: PRODUCTS/SERVICES OFFERED
• TABLE 106 RHO, INC.: PRODUCTS/SERVICES OFFERED
• TABLE 107 RHO, INC.: KEY DEVELOPMENTS

LIST OF FIGURES

• FIGURE 1 MARKET SYNOPSIS
• FIGURE 2 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
• FIGURE 4 MARKET DYNAMICS: GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• FIGURE 5 DRIVERS: IMPACT ANALYSIS
• FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
• FIGURE 7 VALUE CHAIN ANALYSIS: FUNCTIONAL SERVICE PROVIDERS MARKET
• FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: FUNCTIONAL SERVICE PROVIDERS MARKET
• FIGURE 9 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2022 & 2027 (USD MILLION)
• FIGURE 10 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2022 & 2027 (USD MILLION)
• FIGURE 11 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2022 & 2027 (USD MILLION)
• FIGURE 12 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION 2022 & 2027 (USD MILLION)
• FIGURE 13 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY REGION, 2022
• FIGURE 14 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY COUNTRY 2022
• FIGURE 15 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY COUNTRY, 2022
• FIGURE 16 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY COUNTRY, 2022
• FIGURE 17 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY REGION, 2022
• FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
• FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• FIGURE 20 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET: COMPETITIVE LANDSCAPE
• FIGURE 21 SALES (USD MILLION), 2022
• FIGURE 22 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022
• FIGURE 23 IQVIA INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 24 IQVIA INC.: SWOT ANALYSIS
• FIGURE 25 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 26 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS
• FIGURE 27 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 28 ICON PLC: SWOT ANALYSIS
• FIGURE 29 WUXI APPTEC CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 30 WUXI APPTEC CO., LTD.: SWOT ANALYSIS
• FIGURE 31 PPD INC.: FINANCIAL OVERVIEW SNAPSHOT

Market Overview

The Functional Service Providers (FSP) is anticipated to register a healthy CAGR of 7.49% during the review period.

This market is being driven by various elements, including expanding Research and development ventures, the rising number of clinical preliminaries, and the ascent of FSP outsourcing in drug improvement.

Rising Research and development speculations, particularly in the biopharmaceutical and biotechnology businesses, have made a requirement for functional service providers (FSPs) in the worldwide market. Research showed that the utilization of FSPs by enormous biopharmaceutical organizations is developing at a pace of over 13% yearly. These service providers offer staff to biopharmaceutical and biotechnology organizations for their exploration and advancement projects. They give profoundly qualified research partners, information supervisors, concentrate on organizers, clinical screens, and other related staff backing to these organizations.

Moreover, FSPs offer arrangements like preliminary administration, clinical checking, information the executives, factual programming, biostatistics, clinical composition, lifecycle security, and administrative undertakings. The tedious and costly nature of clinical preliminaries and the issues brought about by the high responsibility bring about the rising notoriety of FSPs. These providers save the organization time and lessen functional expenses.

Segment Insights

Segmentation of the global functional service provider market by type includes clinical monitoring, medical publishing, data management, pharmacovigilance, biostatistics/programming, regulatory, and others.

Based on phase, the global functional service provider market has been segmented into clinical trial phase and post-approval phase. Based on applications, the global functional service providers industry has been segmented into biopharmaceutical companies, biotechnology companies, medical device companies, and research centers and hubs. University institutes.

Regional Insights

The North America functional service providers market represented the biggest market with a portion of roughly 41% in 2022, because of the created medical care foundation, countless clinical preliminaries, and the presence of significant central participants in the region like IQVIA (US), Parexel (US), and Labcorp Medication Improvement (US).

Europe functional service supplier market represented the second-biggest market share because of innovation headways, expanding medical care consumption, and expanding predominance of ongoing sicknesses. As per the EMA, around 4,000 clinical preliminaries happen consistently across the European Association (EU) nations. Moreover, the Germany functional service supplier held the biggest market share in 2022, and the France functional service providers is extended be the quickest developing market in the Europe region.

The Asia-Pacific functional service providers market is supposed to be the quickest developing from 2023 to 2027 attributable to high understanding populace, decreased expenses of leading preliminaries, and great administrative arrangements. Also, central members working in the Functional Service Providers (FSP) Market are effectively venturing into Asia-Pacific region. For example, in July 2018, Parexel (US) laid out another auxiliary called Wellbeing Advances in Hong Kong to grow its capacities in the APAC region.

Major Players

Key Companies in the Functional Service Providers Market are Quanticate International Limited (UK), IQVIA, Inc. (US), BioPoint Inc. (US), Rho, Inc. (US), KPS Life, LLC (US), Parexel International Corporation (US), Laboratory Corporation of America Holdings (US), Wuxi Apptec co., Ltd. (China), Icon Plc (Ireland), and PPD Inc. (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING R&D INVESTMENTS
  • 4.2.2 RISING NUMBER OF CLINICAL TRIALS
  • 4.2.3 LOWERED OPERATIONAL COSTS AND IMPROVED SERVICE QUALITY
  • 4.2.4 RISE IN FSP OUTSOURCING IN DRUG DEVELOPMENT
• 4.3 RESTRAINTS
  • 4.3.1 DEARTH OF SKILLED LABOR
• 4.4 OPPORTUNITIES
  • 4.4.1 BIOPHARMA AND BIOTECH'S DIGITAL TRANSFORMATION

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
  • 5.1.2 SERVICE CUSTOMIZATION
  • 5.1.3 CUSTOMER PURCHASE SUPPORT
  • 5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON FUNCTIONAL SERVICE PROVIDERS MARKET
  • 5.3.1 OVERVIEW
  • 5.3.2 IMPACT ON DEMAND FOR FUNCTIONAL SERVICE PROVIDERS (FSP)

6 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY TYPE

• 6.1 OVERVIEW
• 6.2 CLINICAL MONITORING
• 6.3 MEDICAL WRITING
• 6.4 DATA MANAGEMENT
• 6.5 PHARMACOVIGILANCE
• 6.6 BIOSTATISTICS/PROGRAMMING
• 6.7 REGULATORY AFFAIRS
• 6.8 OTHERS

7 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY STAGE

• 7.1 OVERVIEW
• 7.2 CLINICAL DEVELOPMENT
• 7.3 POST APPROVAL

8 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY APPLICATION

• 8.1 OVERVIEW
• 8.2 BIOPHARMA COMPANIES
• 8.3 BIOTECH COMPANIES
• 8.4 MEDICAL DEVICES COMPANIES
• 8.5 RESEARCH CENTER AND ACADEMIC INSTITUTES

9 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 UK
  • 9.3.3 FRANCE
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 JAPAN
  • 9.4.3 INDIA
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 LATIN AMERICA
  • 9.5.2 MIDDLE EAST
  • 9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• 10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCHES
  • 10.6.2 PARTNERSHIPS
  • 10.6.3 ACQUISITIONS
• 10.7 MAJOR PLAYERS FINANCIAL MATRIX
  • 10.7.1 SALES (USD MILLION), 2022
  • 10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

• 11.1 IQVIA INC.
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 SOLUTIONS/SERVICES OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS/SERVICES OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 ICON PLC
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS/SERVICES OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 KPS LIFE, LLC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS/SERVICES OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 WUXI APPTEC CO., LTD.
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 SOLUTIONS/SERVICES OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 PPD INC.
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 SOLUTIONS/SERVICES OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 PAREXEL INTERNATIONAL CORPORATION
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS/SERVICES OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 QUANTICATE INTERNATIONAL LIMITED
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS/SERVICES OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 BIOPOINT INC.
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS/SERVICES OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 RHO, INC.
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS/SERVICES OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS